{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T16:33:02Z","timestamp":1775320382001,"version":"3.50.1"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Through the analysis of two successfully treated cases of acute invasive fungal rhino-sinusitis (AIFRS) caused by Mucor in our hospital, to enhance the understanding of this disease and explore improved diagnostic and treatment strategies. This study also conducted a comprehensive literature review of AIFRS. This study also provides a comprehensive literature review of Infections of the mucor and aspergillus genera.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The clinical data of two patients with AIFRS admitted to our hospital from 2022 to 2025 were retrospectively analyzed, focusing on risk factors, clinical manifestations, treatment plans, and outcomes. Additionally, we reviewed and analyzed cases of Infections of the Mucor and Aspergillus genera published in PubMed over the past 15\u202fyears (2011\u20132025).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 387 cases were included in the analyzed studies. The patient cohort was systematically categorized into two main groups: those with Mucor infection and those with Aspergillus infection. Within the Mucor infection group, four subgroups were further identified. The average age of patients infected with Mucor was 41\u202f\u00b1\u202f31.11\u202fyears, while that of patients infected with Aspergillus was 32.5\u202f\u00b1\u202f29.99\u202fyears. Since the sample size in some subgroups was less than 5 cases, we chose Fisher\u2019s exact test to calculate whether there were significant differences, the efficacy rate of isavuconazole monotherapy (89.47%) was significantly higher than that of amphotericin B monotherapy (59.68%),\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.05. Similarly, the efficacy rate of isavuconazole combination therapy (86.67%) was significantly superior to that of amphotericin B monotherapy (59.68%),\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.05. Amphotericin B combination therapy demonstrated a marginally better efficacy rate (76.92%) compared to amphotericin B monotherapy (59.68%),\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.05.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      In the described cases, ours patients received isavuconazole pre- and post-surgery, achieving favorable prognostic outcomes. Literature comparisons further validate these findings, demonstrating that the efficacy of the new triazole drug isavuconazole in treating invasive aspergillosis and mucormycosis significantly surpasses that of amphotericin B, with efficacy comparable to voriconazole (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.05). These results provide valuable guidance for clinical medication decisions.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1700685","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T05:45:35Z","timestamp":1768196735000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Isavuconazole in the treatment of acute invasive fungal sinusitis: two case reports and literature review"],"prefix":"10.3389","volume":"12","author":[{"given":"Kun","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuwan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huhuifen","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1002\/lary.30251","article-title":"Risk stratification of acute invasive fungal rhinosinusitis in patients with hematologic pathology","volume":"133","author":"Navuluri","year":"2023","journal-title":"Laryngoscope"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e27222","DOI":"10.7759\/cureus.27222","article-title":"Invasive fungal Rhinosinusitis in the era of COVID-19: is it an emerging association?","volume":"14","author":"Chatzisouleiman","year":"2022","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.ijporl.2012.06.026","article-title":"Phoma and Acremonium invasive fungal rhinosinusitis in congenital acute lymphocytic leukemia and literature review","volume":"76","author":"Roehm","year":"2012","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.1038\/s41598-020-60719-7","article-title":"Treatment outcomes in acute invasive fungal rhinosinusitis extending to the extrasinonasal area","volume":"10","author":"Nam","year":"2020","journal-title":"Sci Rep"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/moo.0000000000000507","article-title":"Updates in management of acute invasive fungal rhinosinusitis","volume":"27","author":"Craig","year":"2019","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/8832043","article-title":"Posttranslational modifications in Ferroptosis","volume":"2020","author":"Wei","year":"2020","journal-title":"Oxidative Med Cell Longev"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neures.2013.07.005","article-title":"Mitochondrial ferritin in neurodegenerative diseases","volume":"77","author":"Yang","year":"2013","journal-title":"Neurosci Res"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/cea.12118","article-title":"Fungal rhinosinusitis: what every allergist should know","volume":"43","author":"Callejas","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.asjsur.2022.05.006","article-title":"Diagnostic and therapeutic strategies of acute invasive fungal rhinosinusitis","volume":"46","author":"Luo","year":"2023","journal-title":"Asian J Surg"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1128\/cmr.18.3.556-569.2005","article-title":"Novel perspectives on mucormycosis: pathophysiology, presentation, and management","volume":"18","author":"Spellberg","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1136\/bjophthalmol-2015-306945","article-title":"Invasive fungal disease of the sinus and orbit: a comparison between mucormycosis and aspergillus","volume":"100","author":"Trief","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/moo.0000000000000993","article-title":"Invasive fungal rhinosinusitis: current evidence and research opportunities","volume":"33","author":"Ji","year":"2025","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3390\/jof8080879","article-title":"Breakthrough acute necrotizing invasive fungal rhinosinusitis by Alternaria alternata in a patient with acute lymphoblastic leukemia on anidulafungin therapy and case-based literature review","volume":"8","author":"Tyrellis","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s12105-016-0690-0","article-title":"Pathology of fungal Rhinosinusitis: A review","volume":"10","author":"Montone","year":"2016","journal-title":"Head Neck Pathol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12879-023-08177-0","article-title":"Is low dose of liposomal amphotericin B effective in management of acute invasive fungal rhinosinusitis? Our conclusions from Al-Mowassat university hospital, Syria: a prospective observational study","volume":"23","author":"Alabdullah","year":"2023","journal-title":"BMC Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1177\/08465371241227424","article-title":"Imaging features of invasive fungal Rhinosinusitis: A systematic review","volume":"75","author":"Chen","year":"2024","journal-title":"Can Assoc Radiol J"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.mib.2020.07.001","article-title":"Immunometabolism in fungal infections: the need to eat to compete","volume":"58","author":"Weerasinghe","year":"2020","journal-title":"Curr Opin Microbiol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.2174\/0118715249274215231205062701","article-title":"Molecular pathway, epidemiological data and treatment strategies of fungal infection (mycoses): A comprehensive review","volume":"24","author":"Singh","year":"2024","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"fuab005","DOI":"10.1093\/femsre\/fuab005","article-title":"In vitro infection models to study fungal-host interactions","volume":"45","author":"Last","year":"2021","journal-title":"FEMS Microbiol Rev"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41579-024-01062-w","article-title":"The pathobiology of human fungal infections","volume":"22","author":"Brown","year":"2024","journal-title":"Nat Rev Microbiol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1002\/lary.31463","article-title":"Invasive fungal sinusitis in an immunocompetent patient after sinus surgery for chronic Rhinosinusitis with nasal polyps and a Mycetoma","volume":"134","author":"Patel","year":"2024","journal-title":"Laryngoscope"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/moo.0000000000000947","article-title":"Infectious disease for the rhinologist","volume":"32","author":"Png","year":"2024","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"115010","DOI":"10.1016\/j.ejmech.2022.115010","article-title":"Mucormycosis: A hidden mystery of fungal infection, possible diagnosis, treatment and development of new therapeutic agents","volume":"246","author":"Hussain","year":"2023","journal-title":"Eur J Med Chem"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3390\/jof10040278","article-title":"Amphotericin B in the era of new antifungals: where will it stand?","volume":"10","author":"Akinosoglou","year":"2024","journal-title":"J Fungi"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.medcli.2024.01.045","article-title":"Invasive aspergillosis: A comprehensive review","volume":"163","author":"Machado","year":"2024","journal-title":"Med Clin"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e0014223","DOI":"10.1128\/cmr.00142-23","article-title":"Advancements and challenges in antifungal therapeutic development","volume":"37","author":"Puumala","year":"2024","journal-title":"Clin Microbiol Rev"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.jiph.2022.08.004","article-title":"Development and research progress of anti-drug resistant fungal drugs","volume":"15","author":"Cui","year":"2022","journal-title":"J Infect Public Health"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.riam.2025.01.005","article-title":"Experience with isavuconazole in the treatment of mucormycosis and breakthrough fungal infections","volume":"42","author":"Garcia-Vidal","year":"2025","journal-title":"Rev Iberoam Micol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/ftd.0000000000000952","article-title":"Antifungal drugs TDM: trends and update","volume":"44","author":"Kably","year":"2022","journal-title":"Ther Drug Monit"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e0017722","DOI":"10.1128\/aac.00177-22","article-title":"New perspectives on antimicrobial agents: isavuconazole","volume":"66","author":"Lewis","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1080\/14787210.2023.2224564","article-title":"Part 2: mucormycosis: focus on therapy","volume":"21","author":"Lynch","year":"2023","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3390\/antibiotics11030344","article-title":"Isavuconazole in the treatment of aspergillus fumigatus fracture-related infection: case report and literature review","volume":"11","author":"Mertens","year":"2022","journal-title":"Antibiotics"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1093\/cid\/ciaa358","article-title":"Isavuconazole as primary antifungal prophylaxis in patients with acute myeloid leukemia or myelodysplastic syndrome: an open-label, prospective, phase 2 study","volume":"72","author":"Bose","year":"2021","journal-title":"Clin Infect Dis"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jiac.2022.10.010","article-title":"Efficacy and safety of isavuconazole against deep-seated mycoses: A phase 3, randomized, open-label study in Japan","volume":"29","author":"Kohno","year":"2023","journal-title":"J Infect Chemother"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/myc.13622","article-title":"A systematic review and meta-analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections","volume":"66","author":"Kato","year":"2023","journal-title":"Mycoses"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1700685\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T05:45:37Z","timestamp":1768196737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1700685\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":35,"alternative-id":["10.3389\/fmed.2025.1700685"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1700685","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"article-number":"1700685"}}